Forte Biosciences Price Chart
Forte Biosciences Volume Chart
Forte Biosciences Market Segments
Premarket
+2.48(+10.06%)
| Open | $24.65 |
|---|---|
| Close | $27.13 |
| Low | $24.65 |
| Low Change | 0.00 (0.00%) |
| High | $27.35 |
| High Change | +2.70 (+10.95%) |
| Range | $2.70 |
| Volume | 616 |
| Dollar Volume | $16.71K |
After Hours Yesterday
+1.01(+4.02%)
| Open | $25.13 |
|---|---|
| Close | $26.14 |
| Low | $25.11 |
| Low Change | -0.02 (-0.08%) |
| High | $42.00 |
| High Change | +16.87 (+67.13%) |
| Range | $16.89 |
| Volume | 6.515K |
| Dollar Volume | $170.30K |
Regular Trading Hours Yesterday
-0.58(-2.18%)
| Open | $26.55 |
|---|---|
| Close | $25.97 |
| Low | $25.44 |
| Low Change | -1.11 (-4.18%) |
| High | $28.03 |
| High Change | +1.48 (+5.57%) |
| Range | $2.59 |
| Volume | 239.482K |
| Dollar Volume | $6.22M |
Premarket Yesterday
*No Trades in Segment
Forte Biosciences Moving Averages
| 5 Day Moving Average (SMA5) | $26.28 |
|---|---|
| 10 Day Moving Average (SMA10) | $25.53 |
| 20 Day Moving Average (SMA20) | $26.86 |
| 50 Day Moving Average (SMA50) | $29.07 |
| 100 Day Moving Average (SMA100) | $25.47 |
| 200 Day Moving Average (SMA200) | $18.77 |
Forte Biosciences Statistics
| Average Volume (30 Days) | 214.25K |
|---|---|
| P/E Ratio (Current) | -6.37 |
| EPS (Current) | -$4.13 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$44.57M |
| Cash Ratio | 7.19 |
| Current Ratio | 7.34 |
| Quick Ratio | 7.34 |
| Debt to Equity | 0.00 |
| Enterprise Value | $236.29M |
| EV to EBITDA | -4.43 |
| EV to Sales | — |
| Price to Book | 3.92 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.53% |
| Return on Equity | -0.62% |
Forte Biosciences Stock Splits
There has been 1 stock split for Forte Biosciences (FBRX). The reverse stock split occured on August 28, 2024 and reduced the outstanding shares at a ratio of 25:1.
| Date | Type | Ratio |
|---|---|---|
| Aug 28, 2024 | Reverse | 25:1 |
Forte Biosciences Dividends
There have been no dividends for Forte Biosciences (FBRX).